1. Home
  2. WHLR vs CDT Comparison

WHLR vs CDT Comparison

Compare WHLR & CDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wheeler Real Estate Investment Trust Inc.

WHLR

Wheeler Real Estate Investment Trust Inc.

HOLD

Current Price

$1.86

Market Cap

2.3M

Sector

Real Estate

ML Signal

HOLD

Logo Conduit Pharmaceuticals Inc.

CDT

Conduit Pharmaceuticals Inc.

HOLD

Current Price

$0.61

Market Cap

2.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WHLR
CDT
Founded
2011
2019
Country
United States
United States
Employees
56
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3M
2.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
WHLR
CDT
Price
$1.86
$0.61
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
430.7K
444.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$0.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.65
$0.37
52 Week High
$10.05
$6.00

Technical Indicators

Market Signals
Indicator
WHLR
CDT
Relative Strength Index (RSI) 40.59 27.31
Support Level $1.82 $0.53
Resistance Level $2.25 $1.16
Average True Range (ATR) 0.23 0.11
MACD 0.01 -0.02
Stochastic Oscillator 30.69 6.96

Price Performance

Historical Comparison
WHLR
CDT

About WHLR Wheeler Real Estate Investment Trust Inc.

Wheeler Real Estate Investment Trust Inc is a self-managed commercial real estate investment company. It owns, leases, and operates income-producing retail properties with a primary focus on grocery-anchored centers. The company's properties include Alex City Marketplace in Alexander City, Alabama; Bryan Station in Lexington, Kentucky; Cardinal Plaza in Henderson, North Carolina; Clover Plaza in Clover, South Carolina; Winslow Plaza in Sicklerville, New Jersey and many more.

About CDT Conduit Pharmaceuticals Inc.

CDT Equity Inc, formerly Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.

Share on Social Networks: